Amgen Inc. buy Royal Bank of Canada
Start price
02.05.25
/
50%
€247.25
Target price
02.05.26
€283.33
Performance (%)
15.99%
Price
15:49
€279.65
Summary
This prediction is currently active. The prediction currently has a performance of 15.99%. Dividends of €7.14 are taken into consideration when calculating the performance. This prediction currently runs until 02.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 3.001% | 3.001% |
| iShares Core DAX® | 0.060% | 1.215% |
| iShares Nasdaq 100 | -3.065% | -0.519% |
| iShares Nikkei 225® | -2.094% | -3.066% |
| iShares S&P 500 | -1.657% | -0.069% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Royal Bank of Canada from $324.00 to $320.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat